NeuroBell

NeuroBell

Private
CorkHealthcare & Life Scienceshttps://www.neurobell.com/

Last Round

Seed

Dec 1, 2023

Total Funding Raised

$2.32M

Momentum Score

50 /100

Company Overview

NeuroBell is a medical devices company that develops a portable EEG monitoring device with automated, real-time seizure detection for newborns.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

neonatal EEGAI seizure detectionportable EEGnewborn seizure detectionEEGNICUMedTechclinical decision supportbrain monitoringAI diagnosticsneonatal brain injuryFDA 510(k) clearancedisposable medical deviceelectroencephalogramneonatal intensive care unitedge AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NeuroBell Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

NeuroBell Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedDec 1, 2023

Key People

Founding team and executive leadership

Mark O'Sullivan

Co-founder & CEO

Founding Team

Colm Murphy

Chief Technology Officer

Executive Team

NeuroBell Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 20, 2025

    Grew 23% QoQ, from 13 to 16 employees.

  • Dec 11, 2024

    Grew 30% QoQ, from 10 to 13 employees.

NeuroBell Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

NeuroBell Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NeuroBell's valuation, stock price, and market status.

Firmographic Details

HeadquartersCork
Employee Range15
Year Founded2023
Last FundingDec 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.